FDA grants accelerated approval to enfortumab vedotin-ejfv for metasta
Oncology news burst
Related Articles
FDA approves mitomycin intravesical solution for recurrent low-grade
On June 12, 2025, the Food and Drug Administration approved mitomycin intravesical solution (Zusduri, UroGen Pharma) for adult patients with recurrent low-grade
Dosage Optimization of Pediatric Oncology Products: Our Patients Deserve Better – PubMed
Despite survival gains for many pediatric cancers since the 1970s, cancer remains the leading cause of death by disease for children and adolescents in the…
FDA approves darolutamide
On June 3, 2025, the Food and Drug Administration (FDA) approved darolutamide.
FDA approves darolutamide
On June 3, 2025, the Food and Drug Administration (FDA) approved darolutamide.
FDA approves darolutamide
On June 3, 2025, the Food and Drug Administration (FDA) approved darolutamide.
FDA approves darolutamide
On June 3, 2025, the Food and Drug Administration (FDA) approved darolutamide.
Artificial Intelligence and Machine Learning Innovations to Improve Design and Representativeness in Oncology Clinical Trials
The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive…
Program Guide – ASCO Meeting Program Guide
Jennifer Gao Oncology Center of Excellence, U.S. Food and Drug Administration, Silver Spring, MD Jennifer Gao, Joyce Cheng, Mallorie Fiero, Shenghui Tang, Suparna Wedam, Melanie…
Artificial Intelligence and Machine Learning Innovations to Improve Design and Representativeness in Oncology Clinical Trials
The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive…
Artificial Intelligence and Machine Learning Innovations to Improve Design and Representativeness in Oncology Clinical Trials
The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive…